PURCELLVILLE, Va. June 15, 2020 - Aperiomics, a biotechnology company deploying advanced technologies to identify the root causes of infectious disease, announced today that it has entered into a partnership with the Town of Purcellville, Virginia to host a COVID-19 testing day on Friday, June 19, 2020, from 9am to 7pm outside the former Rite Aid location (801 E. Main Street, Purcellville) on the corner of East Main Street and Ken Culbert Jr. Road in Purcellville.
Aperiomics will be administering both RT-PCR Tests for active infection along with IgM/IgG Antibody tests for COVID antibodies. Both tests can be performed quickly, with results returned in 12-72 hours for this event. By looking for both current infections and developed antibodies, public health officials can achieve a more complete picture of how the virus has spread in the community, including who may have previously been exposed and recovered and potentially immune to the virus.
Participants in this event will pay $150 for both virus and antibody testing. Those tested will get a superbill that can be submitted for potential insurance reimbursement if they meet medical guidelines for reimbursable testing.
Medical professionals, municipal leaders, and business owners interested in conducting their own COVID-19 testing with Aperiomics should contact the company at orders@aperiomics.com or 703-229-0406.
About Aperiomics
The only company of its kind and scope in the world combining advanced DNA testing, the power of big data and decades of infectious disease expertise, Aperiomics is revolutionizing the way that medical professionals around the world identify infections. Supported by the National Science Foundation, Aperiomics identifies every known bacterium, virus, fungus, and parasite through deep shotgun metagenomic sequencing, using its proprietary, world-renowned database containing nearly 40,000 microorganisms. Helping doctors and their patients identify the causes of infections that other tests cannot identify, Aperiomics streamlines the path to a positive clinical outcome. Aperiomics was named Life Science Innovator of the Year in 2016 and International Start Up of the Year in 2018. www.aperiomics.com
